Evaluation of p53 mutations in premalignant esophageal lesions and esophageal adenocarcinoma using laser capture microdissection

Modern Pathology

Volumn 17, Issue 11, 2004, Pages 1323-1327

  Djalilvand, Azita ^a   Pal, Rinku ^a   Goldman, Harvey ^a   Antonioli, Donald ^a   Kocher, Olivier ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Barrett's esophagus; Comparative genomic hybridization; Dysplasia; Laser capture microdissection; p53; Polymerase chain reaction

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CELL ISOLATION; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA SEQUENCE; DYSPLASIA; EPITHELIUM CELL; ESOPHAGUS CARCINOMA; ESOPHAGUS TUMOR; EXON; GASTRITIS; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; METAPLASIA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH ANTRUM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BASE SEQUENCE; ESOPHAGEAL NEOPLASMS; GENES, P53; HUMANS; LASERS; MICRODISSECTION; PARAFFIN EMBEDDING; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 8144228951     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800231     Document Type: Article

References (29)

1. Phillips RW, Wong RKH. Barrett's esophagus. Natural history, incidence, etiology and complications. Gastroenterol Clin North Am 1991;20:791-816.
2. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-1536.
3. Spechler SJ. Laser photoablation of Barrett's epithelium: burning issues about burning tissues. Gastroenterology 1993;104;1855-1858.
4. Ming S-C. Adenocarcinoma and other epithelial tumors of the esophagus. In: Ming S-C, Goldman H (eds). Pathology of the Gastrointestinal Tract, 2nd edn. Williams&Wilkins: Baltimore, MD, 1998, pp 503-509.
5. Gramlich TL, Fritsch C, Cohen C, et al. Oncogene expression and amplification in Barrett adenocarcinoma. Int J Surg Pathol 1997;4:203-212.
6. Souza RF, Meltzer SJ. The molecular basis for carcinogenesis metaplastic columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:583-597.
7. Neshat K, Sanchez CA, Galipeau PC, et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994;106:1589-1595.
8. Galipeau PC, Cowan DS, Sanchez CA, et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci USA 1996;93:7081-7084.
9. Wong DJ, Barrett MT, Stoger R, et al. p16NK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res 1997;57:2619-2622.
10. Galipeau PC, Prevo LJ, Sanchez CA, et al. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 1999;91:2087-2095.
11. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin Proc 2001;76:438-446.
12. Walch AK, Zitzelsberger HF, Bruch J, et al. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol 2000;156:555-566.
13. Reid BJ, Haggitt RC, Rubin CE, et al. Flow cytometry complements histology in detecting patients at risk for Barrett's adenocarcinoma. Gastroenterology 1987;93:1-11.
14. Fennerty MB, Sampliner RE, Way D, et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989;97:815-820.
15. Bian YS, Osterheld MC, Bosman FT, et al. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol 2001;14:397-403.
16. Coggi G, Bosari S, Roncalli M, et al. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer 1997;79:425-432.
17. Kubba AK, Pool NA, Watson A. Role of p53 assessment in management of Barrett's esophagus. Dig Dis Sci 1999;44:659-667.
18. Casson AG, Mukhopadhyay T, Cleary KR, et al. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991;51(16): 4495-4499.
19. Audrezet MP, Robaszkiewicz M, Mercier B, et al. TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res 1993;53:5745-5749.
20. Gao H, Wang L-D, Zhou Q, et al. p53 tumor suppressor gene mutation in early esophageal precancerous lesion and carcinoma among high-risk populations in Henan, China. Cancer Res 1994;54:4342-4346.
21. Wagata T, Shibagaki I, Imamura M, et al. Loss of 17p, mutations of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 1993;53:846-850.
22. Moore JH, Lesser EJ, Erdody DH, et al. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer 1994;56:487-493.
23. Casson AG, Manolopoulos B, Troter M, et al. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Am J Surg 1994;167:52-57.
24. Prevo LJ, Sanchez CA, Galipeau PC, et al. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999;59:4784-4787.
25. Schneider PM, Casson AG, Levin B, et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg 1996;111:323-333.
26. Dunn JR, Garde J, Dolan K, et al. The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens. Clin Cancer Res 2000;6:4033-4042.
27. Bhargava P, Eisen GM, Holterman DA, et al. Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus. Am J Clin Pathol 2000;114:552-563.
28. Reid BJ, Prevo LJ, Galipeau PC, et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 2001;96:2839-2848.
29. Giménez A, Minguela A, Parrilla P, et al. Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with Barrett's esophagus. Cancer 1998;83: 641-651.